Why Tracking Your Biomarkers Over Time Matters More Than a Single Test

Imagine taking a single photograph of a river and trying to determine whether it’s rising, falling, or staying the same. Without context — without knowing what it looked like yesterday, last month, or last year — that single image tells you very little. The same principle applies to your blood test results. A single set of numbers is a snapshot, but a series of results tracked over time reveals a story — one that can be the difference between catching a disease early and missing it entirely.

The Limitations of a Single Blood Test

Most Australians, if they get blood tests at all, receive their results, glance at whether anything is flagged as abnormal, and file the report away. If everything falls within the reference range, they assume all is well. But this approach has significant blind spots.

Reference ranges are broad statistical averages derived from large populations. They define "normal" as the range within which 95% of a healthy population falls. This means a result can be technically normal yet represent a significant shift for you as an individual. For instance, if your fasting glucose has risen from 4.2 mmol/L to 5.3 mmol/L over three years, both values are within the normal range — but the trend clearly indicates declining metabolic health and increasing diabetes risk.

Furthermore, blood test results can fluctuate based on factors such as hydration, recent meals, physical activity, stress, sleep quality, and even the time of day. A single result captures all of these variables at one moment, making it an unreliable basis for major clinical decisions without additional context.

The Power of Longitudinal Tracking

Longitudinal biomarker tracking — the practice of recording and analysing your results over months and years — transforms blood tests from static snapshots into dynamic health intelligence. This approach offers several critical advantages.

First, it enables the detection of trends before they become problems. A gradual decline in eGFR (kidney function) from 95 to 72 over five years might never trigger a single abnormal flag, yet it represents a meaningful deterioration that warrants investigation and intervention. Similarly, a slow rise in LDL cholesterol can be addressed with lifestyle modifications long before it reaches levels requiring medication.

Second, longitudinal tracking establishes your personal baseline. Population reference ranges don’t account for individual variation. Your "normal" TSH might sit at 1.2 mIU/L, and a jump to 3.8 mIU/L — still technically within the reference range — could indicate early thyroid dysfunction. Without historical data, this shift would be invisible.

Third, tracking allows you to measure the impact of interventions. If you’ve changed your diet, started exercising, begun a new supplement, or altered your medication, longitudinal data shows you exactly how your body is responding. This closes the feedback loop and empowers evidence-based decision-making rather than guesswork.

What the Research Says

The concept of using individual longitudinal data rather than population-based reference ranges is well established in laboratory medicine. It’s known as "reference change value" (RCV) analysis, and research has demonstrated that it significantly improves the detection of clinically meaningful changes. A landmark study by Fraser and Harris showed that for many biomarkers, within-individual variation is substantially smaller than between-individual variation — meaning that relying solely on population reference ranges misses changes that are significant for the individual.

In Australia, the growing field of precision medicine is increasingly recognising the importance of longitudinal health data. The CSIRO has highlighted personalised health monitoring as a key pillar of future healthcare, and Australian research institutions are investing heavily in tools and platforms that enable individuals to track their own health metrics over time.

Which Biomarkers Should You Track?

While virtually any blood test result benefits from longitudinal tracking, some markers are particularly valuable to monitor over time:

Metabolic markers: Fasting glucose, HbA1c, and fasting insulin are essential for tracking metabolic health and diabetes risk. These markers often shift gradually over years before crossing diagnostic thresholds.

Lipid markers: Total cholesterol, LDL, HDL, and triglycerides can fluctuate seasonally and in response to dietary changes. Long-term trends are far more meaningful than individual readings.

Inflammatory markers: High-sensitivity CRP (hs-CRP) is a marker of systemic inflammation linked to cardiovascular disease, autoimmune conditions, and even certain cancers. Tracking this over time can reveal chronic low-grade inflammation that a single reading might dismiss.

Organ function markers: Liver enzymes (ALT, AST, GGT), kidney function (eGFR, creatinine), and thyroid hormones (TSH) should all be monitored longitudinally. Gradual changes in these markers often precede overt organ dysfunction by years.

Nutritional markers: Vitamin D, iron studies (particularly ferritin), and vitamin B12 are common deficiencies in Australia and respond well to supplementation — but only if you can verify the response through follow-up testing.

How Yearly Makes Tracking Simple

Historically, tracking biomarkers over time meant keeping paper records or maintaining complicated spreadsheets. Today, platforms like Yearly are purpose-built for this task. By uploading your pathology results, Yearly’s AI analyses your data, identifies trends, and presents your biomarker trajectories in clear, visual formats. You can see at a glance whether your metabolic health is improving, stable, or declining — and share these insights with your healthcare provider for more productive consultations.

Taking a Proactive Approach

The shift from reactive to proactive healthcare is one of the defining health trends of our time. Rather than waiting for disease to announce itself through symptoms, Australians are increasingly choosing to monitor their health actively and intervene early. Longitudinal biomarker tracking is the cornerstone of this approach — it gives you the data, the context, and the confidence to take control of your health journey.

Start by requesting comprehensive blood tests from your GP at least once a year. Store your results digitally, and compare them against your own history, not just population averages. Your future self will thank you.

References

1. Fraser, C.G. and Harris, E.K. "Generation and application of data on biological variation in clinical chemistry." Critical Reviews in Clinical Laboratory Sciences, vol. 27, no. 5, 1989, pp. 409–437.
2. Ricós, C. et al. "Current databases on biological variation: pros, cons and progress." Scandinavian Journal of Clinical and Laboratory Investigation, vol. 59, no. 7, 1999, pp. 491–500.
3. CSIRO. "Future of Health: Shifting Australia’s focus from illness treatment to health and wellbeing management." 2018.
4. The Royal Australian College of General Practitioners (RACGP). "Guidelines for preventive activities in general practice." 10th Edition, 2025.